Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factors affecting warfarin requirements. A prospective population study.

P A Routledge, P H Chapman, D M Davies

    European Journal of Clinical Pharmacology
    |June 12, 1979
    PubMed
    Summary

    Warfarin dose requirements decrease with age, especially in patients with a history of venous thromboembolism or coronary artery disease. Patient weight also influences warfarin dosage but is less critical than age.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Engineering of chimeric natural killer cell receptors to develop precision adoptive immunotherapies for cancer.

    Clinical and experimental immunology·2020
    Same author

    Full annual monitoring of Subantarctic Emiliania huxleyi populations reveals highly calcified morphotypes in high-CO<sub>2</sub> winter conditions.

    Scientific reports·2020
    Same author

    The impact of phosphorus on interactions of the hemiparasitic angiosperm Rhinanthus minor and its host Lolium perenne.

    Oecologia·2017
    Same author

    Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.

    British journal of clinical pharmacology·2015
    Same author

    A comparative study of methyldopa and labetalol in the treatment of hypertension.

    British journal of clinical pharmacology·2015
    Same author

    Mean steady-state plasma concentrations of labetalol in patients undergoing antihypertensive therapy.

    British journal of clinical pharmacology·2015

    Area of Science:

    • Pharmacology
    • Geriatrics
    • Cardiovascular Medicine

    Background:

    • Warfarin is a common anticoagulant medication.
    • Dosage adjustments are crucial for effective anticoagulation.
    • Factors influencing warfarin dosage require further investigation.

    Purpose of the Study:

    • To investigate the relationship between patient age and warfarin dose requirements.
    • To determine if patient weight affects warfarin dosage.
    • To identify specific patient subgroups where age significantly impacts warfarin dose.

    Main Methods:

    • Analysis of warfarin dosage in 228 ambulatory patients.
    • Statistical evaluation of age and weight as determinants of warfarin dose.
    • Subgroup analysis based on medical history (venous thromboembolism, coronary artery disease).

    Related Experiment Videos

    Main Results:

    • A progressive decline in warfarin dose was observed with increasing age from the third decade onwards.
    • The age-related decline in warfarin dose was significant in patients with a history of venous thromboembolism or coronary artery disease.
    • Patient weight was related to warfarin requirements but was a less significant factor than age.

    Conclusions:

    • Age is a significant determinant of warfarin dose, particularly in older patients and those with specific cardiovascular conditions.
    • Warfarin dosage management should consider patient age and weight.
    • Further research may refine age-specific dosing guidelines for warfarin therapy.